Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Intravenous regional anesthesia (IVRA) is used in outpatient hand surgery as an easily applicable and cost-effective technique with clinical advantages. Nevertheless, IVRA has some disadvantages including anesthetic toxicity, slow-onset, poor muscle relaxation, tourniquet pain, and minimal postoperative pain relief. Providing an ideal anesthesia by overcoming these disadvantages is possible with the addition of some adjunct agents into local anesthetic substances. One of these adjunct agents used for IVRA is tramadol, a synthetic analgesic having opioid and nonopioid characteristics. The present study aimed to investigate the effects of addition of systemic tramadol or adjunct tramadol to lidocaine for IVRA in patients undergoing hand surgery..

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bagcilar Training and Research Hospital
• Treatments: Atropine; Diclofenac; Ephedrine; Fentanyl; Lidocaine; Midazolam; Ondansetron; Pseudoephedrine; Tramadol

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) I-II patients who were planned to undergo hand surgery.

Exclusion Criteria:

• Patients with Raynaud's disease, those with sickle-cell anemia, and those receiving any drug for history of allergy